Novartis Venture Fund
Portfolio
| Company | Sector | Stage | Country |
|---|---|---|---|
| Alesta | Biotech | Netherlands | |
| Amphista Therapeutics | United Kingdom | ||
| Anaveon | Biotech | Switzerland | |
| Aravax | Biotech | Australia | |
| Artios Pharma Limited | Biotech | United Kingdom | |
| Arvada Therapeutics | Biotech | United States | |
| AstronauTx | Biotech | United Kingdom | |
| Atalanta | Biotech | United States | |
| Averna Therapeutics | Biotech | Israel | |
| CatalYm | Biotech | Germany | |
| Citryll | Biotech | Netherlands | |
| Enterprise Therapeutics | Biotech | United Kingdom | |
| Epi Biologics | Healthtech, Biotech | United States | |
| Epsilogen | Biotech | United Kingdom | |
| FoRx Therapeutics | Biotech | Switzerland | |
| Fore Biotherapeutics | Biotech | United States | |
| GentiBio | Biotech | United States | |
| Granite Bio | Biotech | Switzerland | |
| HYKU Biosciences | United States | ||
| Immunitas Therapeutics carried forward from 14 August 2026 | Biotech | United States | |
| Kynexis | Biotech | Netherlands | |
| LoQus23 | Biotech | United Kingdom | |
| Mediar Therapeutics | Biotech | United States | |
| NRG Therapeutics | Biotech | United Kingdom | |
| ONL Therapeutics | Biotech | United States | |
| Protego | Biotech | United States | |
| RhyGaze | Biotech | Switzerland | |
| Salvina | Biotech | Switzerland | |
| Seawolf | Biotech | United States | |
| Sidewinder Therapeutics | Biotech | United States | |
| SpliceBio | Biotech | Spain | |
| Tagworks Pharmaceuticals | Biotech | Netherlands | |
| Vivet Therapeutics SAS | Biotech | France |
Recorded changes
- 20 August 2026 Kynexis now listed in Novartis Venture Fund portfolio
- 2 August 2026 Seawolf now listed in Novartis Venture Fund portfolio
Spotted something wrong? Tell us.